The massive potential dilution (37.3% of outstanding shares) and the need for a new vote on an already contested proxy slate increase the risk of shareholder rejection. Monitor proxy advisory firm recommendations and early vote tallies ahead of the November 10 meeting.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 28 $0.6116entry
- T+1 · 7d ago −5.61%α −3.84% · $0.5773
- T+5 · due 14h ago Pending
- T+5 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Health In Tech filed a DEFA14A supplement to its proxy statement, further increasing the proposed equity incentive plan share reserve from 20,677,849 to 30,677,849 shares (a 20,000,000 share increase). The additional shares are primarily to fund contingent equity awards for newly appointed CEO Sanjay Shrestha, including 2,500,000 shares of market capitalization-based restricted stock. The amendment requires stockholder approval at the November 10, 2026 annual meeting and all previously submitted proxies are voided.
Key Financial Metrics
Key Facts
- Board revised Proposal Four to increase the 2024 Plan share reserve from 10,677,849 to 30,677,849 shares of Class A Common Stock, an increase of 20,000,000 shares.
- The 20,000,000 additional shares represent approximately 37.3% of the 53,600,790 Class A shares outstanding as of the record date.
- CEO Sanjay Shrestha was granted contingent restricted stock awards totaling up to 8,000,000 shares, with 2,500,000 shares (MC-2, MC-3, MC-4 tranches) contingent on stockholder approval of this amendment.
- Previously submitted proxies are voided; stockholders must submit new votes using the updated proxy card.
- The annual meeting is scheduled for November 10, 2026, with a record date of September 18, 2026.
Financial Impact
Potential dilution of approximately 37.3% of outstanding Class A Common Stock if the full 20,000,000 share increase is issued.
Risk Factors
- Shareholder rejection of the amended proposal would forfeit 2,500,000 shares of CEO contingent awards, potentially impacting retention.
- The company is already out of compliance with Nasdaq board independence requirements, adding governance risk.
- The concurrent authorized share increase proposal (220M to 720M shares) and standby equity purchase agreement with Yorkville add further dilution overhang.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-113394 |
| Document: 0001213900-26-113394-index-headers.html | 0001213900-26-113394 |
| Document: 0001213900-26-113394-index.html | 0001213900-26-113394 |
| Document: 0001213900-26-113394.txt | 0001213900-26-113394 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 7d ago | DEFA14A | $0.6116 | awaiting T+60 | awaiting T+60 | $0.5740 (+6.15%) |
Oct 26, 2026 9d ago | 8-K | $0.5750 | awaiting T+60 | awaiting T+60 | $0.5740 (−0.17%) |
Oct 22, 2026 13d ago | 3 | $0.5623 | awaiting T+60 | awaiting T+60 | $0.5740 (+2.08%) |
Oct 16, 2026 19d ago | 8-K | $0.6350 | awaiting T+60 | awaiting T+60 | $0.5740 (+9.61%) |
Oct 16, 2026 19d ago | EFFECT | $0.6520 | awaiting T+60 | awaiting T+60 | $0.5740 (+11.96%) |
Oct 13, 2026 22d ago | DEF 14A | $0.6780 | awaiting T+60 | awaiting T+60 | $0.5740 (+15.34%) |
Oct 9, 2026 26d ago | S-3/A | $0.7200 | awaiting T+60 | awaiting T+60 | $0.5740 (+20.28%) |
Sep 30, 2026 5w ago | Press Release | $0.7380 | awaiting T+60 | awaiting T+60 | $0.5740 (−22.22%) |
Sep 29, 2026 5w ago | SC 13G | $0.8525 | awaiting T+60 | awaiting T+60 | $0.5740 (−32.67%) |
Sep 4, 2026 8w ago | S-3 | $0.9801 | awaiting T+60 | awaiting T+60 | $0.5740 (+41.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers